Between-meal risedronate does not alter bone turnover in nursing home residents

Journal of the American Geriatrics Society

Volumn 54, Issue 5, 2006, Pages 790-795

  Agrawal, Sabina ^a,c   Krueger, Diane C ^a   Engelke, Jean A ^a   Nest, Lori J ^b   Krause, Peggy F ^b   Drinka, Paul J ^b   Binkley, Neil C ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b Wisconsin Veteran's Home   (United States)

^c NONE   (United States)

Author keywords

Aging; Bisphosphonates; Nursing home; Osteoporosis; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; ALKALINE PHOSPHATASE; AMINO TERMINAL TELOPEPTIDE; BIOLOGICAL MARKER; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; PARATHYROID HORMONE; PLACEBO; RISEDRONIC ACID; VITAMIN D; 25-HYDROXYVITAMIN D; BONE DENSITY CONSERVATION AGENT; COLLAGEN TYPE 1; COLLAGEN TYPE I TRIMERIC CROSS LINKED PEPTIDE; COLLAGEN TYPE I TRIMERIC CROSS-LINKED PEPTIDE; DRUG DERIVATIVE; ETIDRONIC ACID; PEPTIDE;

ABDOMINAL PAIN; AGED; AGING; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BONE DENSITY; BONE TURNOVER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DYSPEPSIA; ESOPHAGITIS; ESOPHAGUS ULCER; FEMALE; FOOD INTAKE; FRACTURE; GASTROINTESTINAL SYMPTOM; HEART INFARCTION; HORMONE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; NURSING HOME PATIENT; OSTEOPOROSIS; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; BLOOD; BONE REMODELING; DRUG ADMINISTRATION; DRUG COMBINATION; DRUG EFFECT; NURSING HOME;

AGED; ALKALINE PHOSPHATASE; BONE DENSITY CONSERVATION AGENTS; BONE REMODELING; CALCIUM; COLLAGEN TYPE I; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; ETIDRONIC ACID; FEMALE; HUMANS; MALE; NURSING HOMES; PEPTIDES; VITAMIN D;

EID: 33744980918     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2006.00696.x     Document Type: Article

References (40)

1. Gabrel CS. Characteristics of elderly nursing home current residents and discharges: Data from the 1997 National Nursing Home Survey. Adv Data 2000;312:1-15.
2. The Demographics of Aging in America [on-line]. Population Resource Center, U.S. Bureau of the Census. Available at www.prcdc.org/summaries/aging/ aging.html Accessed December 9, 2005.
3. Nagraj HS, Gergans GA, Mattson DE et al. Osteopenia in the men of a Veterans Administration nursing home. Am J Clin Nutr 1990;51:100-106.
4. Ekman A, Michaelsson K, Ljunghall S et al. Almost all institutionalized women are osteoporotic, when measured by heel and finger ultrasound. J Intern Med 2001;249:173-180.
5. Chandler JM, Zimmerman SI, Girman CJ et al. Low bone mineral density and risk of fracture in white female nursing home residents. JAMA 2000;284:972-977.
6. Zimmerman SI, Girman CJ, Buie VC et al. The prevalence of osteoporosis in nursing home residents. Osteoporos Int 1999;9:151-157.
7. Reginster JY, Deroisy R, Pirenne H et al. High prevalence of low femoral bone mineral density in elderly women living in nursing homes or community-dwelling: A plausible role of increased parathyroid hormone secretion. Osteoporos Int 1999;9:121-128.
8. Kane RS, Burns EA, Goodwin JS. Minimal trauma fractures in older nursing home residents: The interaction of functional status, trauma and site of fracture. J Am Geriatr Soc 1995;43:156-159.
9. Greenspan SL, Myers ER, Kiel DP et al. Fall direction, bone mineral density, and function: Risk factors for hip fracture in frail nursing home elderly. Am J Med 1998;104:539-545.
10. Kinyamu HK, Gallagher CG, Balhorn KE et al. Serum vitamin D metabolites and calcium absorption in normal young and elderly free-living women and in women living in nursing homes. Am J Clin Nutr 1997;65:790-797.
11. Smith RE. Calcium and vitamin D supplementation in nursing home residents. J Am Medical Dir Assoc 2003;4(2 Suppl):S24-S31.
12. Gloth FM, Tobin JD, Sherman SS et al. Is the recommended daily allowance for vitamin D too low for the homebound elderly? J Am Geriatr Soc 1991;39:137-141.
13. Stein MS, Scherer SC, Walton SE et al. Risk factors for secondary hyperparathyroidism in a nursing home population. Clin Endocrinol 1996;44:375-383.
14. Elliott ME, Binkley NC, Carnes M et al. Fracture risks for women in long-term care: High prevalence of calcaneal osteoporosis and hypovitaminosis D. Pharmacotherapy 2003;23:702-710.
15. McMurtry CT, Young SE, Downs RW et al. Mild vitamin D deficiency and secondary hyperparathyroidism in nursing home patients receiving adequate dietary vitamin D. J Am Geriatr Soc 1992;40:343-347.
16. Lips P, Wiersinga A, Van Ginkel FC et al. The effect of vitamin D supplementation on vitamin D status and parathyroid function in elderly subjects. J Clin Endocrinol Metab 1988;67:644-650.
17. Komar E, Nieves J, Cosman F et al. Calcium homeostasis of an elderly population upon admission to a nursing home. J Am Geriatr Soc 1993;41:1057-1064.
18. Lips P. Vitamin D deficiency and secondary hyperparathyroidism in the elderly: Consequences for bone loss and fractures and therapeutic implications. Endocr Rev 2001;22:477-501.
19. Stein MS, Wark JD, Scherer SC et al. Falls related to vitamin D and parathyroid hormone in an Australian nursing home and hostel. J Am Geriatr Soc 1999;47:1195-1201.
20. Bischoff-Ferrari HA, Dawson-Hughes B, Willett WC et al. Effect of vitamin D on falls: A meta-analysis. JAMA 2004;291:1999-2006.
21. Kanis J. Diagnosis of osteoporosis and assessment of fracture risk. Lancet 2002;359:1929-1936.
22. Kanis JA, Black D, Cooper C et al. A new approach to the development of assessment guidelines for osteoporosis. Osteoporos Int 2002;13:527-536.
23. Kanis JA, Johnell O, Oden A et al. Intervention thresholds for osteoporosis in men and women: A study based on data from Sweden. Osteoporos Int 2005;16:6-14.
24. Harris ST, Watts NB, Genant HK et al. Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis. JAMA 1999;282:1344-1352.
25. Reginster JY, Minne HW, Sorensen OH et al. Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Osteoporos Int 2000;11:83-91.
26. Sato Y, Iwamoto J, Tomohiro K et al. Risedronate therapy for prevention of hip fracture after stroke in elderly women. Neurology 2005;64:811-816.
27. Heaney RP, Davies KM, Chen TC et al. Human serum 25- hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr 2003;77:204-210.
28. Cali CM, Kiel DP. An epidemiologic study of fall-related fractures among institutionalized older people. J Am Geriatr Soc 1995;43:1336-1340.
29. Greenspan SE, Schneider DE, McClung MR et al. Alendronate improves bone mineral density in elderly women with osteoporosis residing in long-term care facilities. Ann Intern Med 2002;136:742-746.
30. Hansdottir H, Franzson E, Prestwood K et al. The effect of raloxifene on markers of bone turnover in older women living in long-term care facilities. J Am Geriatr Soc 2004;52:779-783.
31. Lin JH. Bisphosphonates: A review of their pharmacokinetic properties. Bone 1996;18:75-85.
32. Mitchell DY, Heise MA, Pallone KA et al. The effect of dosing regimen on the pharmacokinetics of risedronate. Br J Clin Pharmacol 1999;48:536-542.
33. Brogna A, Ferrara R, Bucceri AM et al. Influence of aging on gastrointestinal transit time. An ultrasonographic and radiographic study. Invest Radiol 1999;34:357-359.
34. Van Vlem B, Schoonjans R, Vanholder R et al. Dyspepsia and gastric emptying in chronic renal failure patients. Clin Nephrol 2001;56:302-307.
35. Hardoff R, Sula M, Tamir A et al. Gastric emptying time and gastric motility in patients with Parkinson's disease. Mov Disord 2001;16:1041-1047.
36. Stepan JJ, Burckardt P, Vaclav H. The effects of three-month intravenous ibandronate on bone mineral density and bone remodeling in Klinefelter's syndrome: The influence of vitamin D deficiency and hormonal status. Bone 2003;33:589-596.
37. Bischoff HA, Stahelin HB, Dick W et al. Effects of vitamin D and calcium supplementation on falls: A randomized controlled trial. J Bone Miner Res 2003;18:343-351.
38. Trivedi DP, Doll R, Khaw KT. Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: Randomized double blind controlled trial. BMJ 2003;326:469-474.
39. Chapuy MC, Arlot ME, Duboeuf F et al. Vitamin D3 and calcium to prevent hip fractures in elderly women. N Engl J Med 1992;327:1637-1642.
40. Kiel DP, Broe KE, Chen TC et al. A higher dose of vitamin D reduces the risk of falls in nursing home residents: A randomized, placebo-controlled, multiple dose study. J Bone Miner Res 2004;19(Suppl 1):S462.